期刊的影响因子--文章列表

期刊文章列表
Xuexi YANG， Ting MEI， Min YU， Youling GONG（Department of Thoracic Oncology and State Key Laboratory of Biotherapy，Cancer Center，West China Hospital，Sichuan University）.Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Oncedaily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters[J].中国肺癌杂志,2022,第6期周彩存（同济大学附属上海市肺科医院肿瘤科）.专家点评[J].中国肺癌杂志,2022,第6期崔舒悦，汤帅，丁晓玲，丁刚（潍坊医学院口腔医学院）.间充质干细胞及其外泌体对肿瘤影响的研究进展[J].中国肺癌杂志,2022,第5期黄小征¹，吴江华²，周立新¹，宋志杰¹，徐婉彤¹，贾玲¹，刁新婷¹，吴琪¹，林冬梅¹（北京大学肿瘤医院暨北京市肿瘤防治研究所病理科，恶性肿瘤发病机制及转化研究教育部重点实验室；天津医科大学肿瘤医院病理科，国家肿瘤临床医学研究中心，天津市“肿瘤防治”重点实验室，天津市恶性肿瘤临床医学研究中心）.非小细胞肺癌不同部位组织样本PD-L1表达水平比较研究[J].中国肺癌杂志,2022,第5期甘彬¹，刘思阳^1,2，吴一龙¹（广东省肺癌研究所广东省人民医院广东省医学科学院；暨南大学附属第一医院血液科，暨南大学医学院血液学研究所，暨南大学教育部再生医学重点实验室）.2021年非小细胞肺癌重要临床研究纵观与解读[J].中国肺癌杂志,2022,第5期杨雪，赵军（北京大学肿瘤医院胸部肿瘤内一科）.EGFR外显子20插入突变阳性NSCLC治疗的临床研究进展[J].中国肺癌杂志,2022,第5期 Daniel Humberto Pozza¹，Ramon Bezerra Andrade de Mello²（Department of Biomedicine Faculty of Medicine and i3s University of Porto 4200-319 Porto；Discipline of Medical Oncology Post-graduation Program in Medicine Nine of July University (UNINOVE) São Paulo）.Treatment Sequencing Strategies in Lung Cancer[J].中国肺癌杂志,2022,第5期柯冀¹，崔健¹，杨兴国¹，杜鑫¹，马波波²，于磊¹（首都医科大学附属北京同仁医院胸外科；首都医科大学康复医学院，中国康复研究中心）.肺腺癌中m6A RNA甲基化修饰特征与免疫微环境相关性分析[J].中国肺癌杂志,2022,第5期程颖¹，Li ZHANG²，Jie HU³，Donglin WANG⁴，Chengping HU⁵，Jianying ZHOU⁶，Lin WU⁷，Lejie CAO⁸，Jiwei LIU⁹，Helong ZHANG¹⁰，Hong SUN¹¹，Ziping WANG¹²，Hongjun GAO¹³，Yuping SUN¹⁴，Ben LI¹⁴，Xiaohan HU¹⁵，Paul SCHWARZENBERGER¹⁵，Luis PAZ-ARES¹⁶，张良¹（吉林省肿瘤医院胸部肿瘤内科；Respiratory Medicine Department，Peking Union Medical College Hospital；Department of Pulmonary Medicine，Zhongshan Hospital Fudan University；Department of Oncology，Chongqing Cancer Hospital；Department of Respirology and Critical Care Medicine，Xiangya Hospital Central South University；Department of Respiratory Diseases，The First Affiliated Hospital of Zhejiang University；Department of Thoracic Medicine，Hunan Cancer Hospital；Department of Respiration，The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)；Department of Oncology，The First Affiliated Hospital of Dalian Medical University；Department of Oncology，Tang Du Hospital，The Fourth Military Medical University；Department of Oncology，The First Affiliated Hospital of Xi'An Jiaotong University；Department of Thoracic Medical Oncology，Beijing Cancer Hospital；Department of Pulmonary Oncology，Affiliated Hospital of Academy of Military Medical Sciences；MSD China；Merck & Co.，Inc.；Department of Medical Oncology，Hospital Universitario 12 de Octubre）.帕博利珠单抗联合化疗作为中国初治转移性鳞状NSCLC患者的一线治疗方案：KEYNOTE-407中国队列研究[J].中国肺癌杂志,2022,第5期陈意，王鑫，孙冰，孟茂斌，王恩敏，袁智勇，庄洪卿（北京大学第三医院肿瘤放疗科；复旦大学附属华山医院肿瘤放疗科；解放军总医院第五医学中心肿瘤放疗科；天津医科大学肿瘤医院肿瘤放疗科；中国医药教育协会肿瘤放射治疗委员会）.抗血管药物治疗放射性脑坏死专家共识[J].中国肺癌杂志,2022,第5期黄川，吴青峻，马超，焦鹏，孙耀光，佟宏峰（北京医院胸外科国家老年医学中心，中国医学科学院老年医学研究院）.肺癌术后特发性肺纤维化急性加重抢救成功病例报道[J].中国肺癌杂志,2022,第5期 Thoracic Surgery Committee，Department of Simulated Medicine，Wu Jieping Medical Foundation.人工智能在肺结节诊治中的应用专家共识（2022年版）[J].中国肺癌杂志,2022,第4期苏志鹏，毛文杰，李斌，郑智中，杨博，任美玉，宋铁牛，冯海明，孟于琪（兰州大学第二医院胸外科，兰州大学第二临床医学院）.人工智能辅助诊断系统预测肺结节早期肺腺癌浸润亚型的临床研究[J].中国肺癌杂志,2022,第4期符程皓¹，蒋以恒¹，葛佳云¹，袁梅²，王俊³（南京医科大学第一临床医学院；南京医科大学第一附属医院影像科；南京医科大学第一附属医院胸外科）.混合磨玻璃结节型肺腺癌脏层胸膜侵犯的临床特征和危险因素分析[J].中国肺癌杂志,2022,第4期江舟，陈建华（中南大学附属肿瘤医院/湖南省肿瘤医院胸内一科）.肺癌抗血管生成治疗：现状、进展与困惑[J].中国肺癌杂志,2022,第4期李婷，周建英，王晴（浙江大学医学院附属第一医院呼吸与危重症医学科）.肺癌患者中耶氏肺孢子菌肺炎的研究进展[J].中国肺癌杂志,2022,第4期肖平¹，张琳琳¹，王瑜²，孟凡路¹，王鑫¹，钟殿胜¹（天津医科大学总医院肿瘤内科；天津医科大学总医院内分泌代谢科）.2例免疫检查点抑制剂联合化疗引发2型糖尿病个案报道[J].中国肺癌杂志,2022,第4期袁博，陈洋，袁竞妍，曾丽忠，杨拴盈（西安交通大学第二附属医院呼吸与危重症医学科）.LINC00668在肺鳞癌中高表达并促进肿瘤细胞的侵袭转移[J].中国肺癌杂志,2022,第4期杨兴国，于磊，余振，高翔，杜鑫（首都医科大学附属北京同仁医院胸外科）.单孔与单操作孔胸腔镜下胸腺瘤切除术的临床疗效比较：一项倾向性评分匹配研究[J].中国肺癌杂志,2022,第4期刘宝东（首都医科大学宣武医院胸外科）.肺部肿瘤热消融联合免疫治疗现状与进展[J].中国肺癌杂志,2022,第4期迟雨佳，刘奕良，赵军（北京大学肿瘤医院北京肿瘤医院北京市肿瘤防治研究所胸部肿瘤内一科）.胸膜间皮瘤免疫治疗研究进展[J].中国肺癌杂志,2022,第4期 Silvia SCOCCIANTI¹；Emanuela OLMETTO²；Valentina PINZI³；Mattia Falchetto OSTI；Rossella Di FRANCO⁵；Saverio CAINI⁶；Paola ANSELMO⁷；Paolo MATTEUCCI⁵；Davide FRANCESCHINI⁸；Cristina MANTOVANI⁹；Giancarlo BELTRAMO¹⁰；Francesco PASQUALETTI¹¹；Alessio BRUNI¹²；Paolo TINI¹³；Emilia GIUDICE¹⁴；Patrizia CIAMMELLA¹⁵；Anna MERLOTTI¹⁶；Sara PEDRETTI¹⁷；Marianna TRIGNANI；Marco KRENGLI¹⁹；Niccolò GIAJ-LEVRA²⁰；Isacco DESIDERI²；Guido PECCHIOLI²¹；Paolo MUTO²²；Ernesto MARANZANO⁷；Laura FARISELLI³；Pierina NAVARRIA⁸；Umberto RICARDI²³；Vieri SCOTTI²；Lorenzo LIVI²；王绿化²⁴（Radiation Oncology Unit，Ospedale Santa Maria Annunziata，Department of Oncology；Radiation Oncology Unit，Azienda Ospedaliero Universitaria Careggi，Department of Experimental and Clinical Biomedical Sciences "Mario Serio"；U.O Radioterapia，Fondazione IRCCS Istituto Neurologico Carlo Besta，Department of Neurosurgery；U.O.C Radioterapia，A.O.U Sant’Andrea Facoltà Medicina e Psicologia Università Sapienza，Department of Medicine，Surgery and Translational Medicine；Istituto Nazionale Tumori IRCCS，Fondazione G. Pascale，Department of Radiotherapy；Institute for Cancer Research，Prevention and Clinical Network (ISPRO)，Cancer Risk Factors and Life-Style Epidemiology Unit；Radiotherapy Oncology Center，S. Maria Hospital，Department of Oncology；Humanitas Research Hospital，Radiotherapy and Radiosurgery Department；Radiotherapy Unit，Department of Oncology；Cyberknife Centro Diagnostico Italiano，Department of Radiology；Radiation Oncology，Azienda Ospedaliero Universitaria Pisana，Department of Translational Medicine；Radiotherapy Unit，University Hospital of Modena，Department of Oncology and Hematology；Radiotherapy Unit，University of Siena，Department of Radiotherapy and Oncology；UOC di Radioterapia，Policlinico Universitario Tor Vergata，Department of Onco-Haematology；Radioterapia Oncologica "G. Prodi," AO-IRCCS Arcispedale S. Maria Nuova，Department of Oncology and Advanced Technology；Radiation Oncology A.S.O. S.Croce e Carle，Department of Radiation Oncology；U.O. Radioterapia Oncologica，Department of Radiation Oncology，ASST Spedali Civili di Brescia e Università degli studi di Brescia；U.O.C. Radioterapia Oncologica，Ospedale Clinicizzato SS Annunziata-Università Chieti G. D’Annunzio，Department of Radiation Oncology；Radiation Oncology，University Hospital Maggiore della Carità，Department of Translational Medicine；IRCCS Ospedale Sacro Cuore Don Calabria，Department of Advanced Radiation Oncology；Neurosurgery Unit，Azienda Ospedaliero Universitaria Careggi，Department of Neurosurgery；Radioterapia Oncologica，Campus Biomedico，Department of Radiation Oncology；University of Turin，Department of Oncology；中国医学科学院肿瘤医院放射治疗科）.免疫疗法联合立体定向放疗治疗非小细胞肺癌脑转移：一项AIRO多中心回顾性研究[J].中国肺癌杂志,2022,第4期首页上一页 2 3 4 5 6 下一页尾页共有6页，转到页

期刊文章列表